Status:
COMPLETED
Diabetic Retinopathy Screening in General Practice
Lead Sponsor:
Aalborg University
Conditions:
Diabetic Retinopathy
Type2 Diabetes
Eligibility:
All Genders
18-70 years
Brief Summary
Diabetic Retinopathy is a microvascular eye complication of diabetes, which can go unnoticed until permanent vision damage has occurred - in worst-case blindness. Timely retinopathy screenings reduce ...
Eligibility Criteria
Inclusion
- Diagnosed with type 2 diabetes
- Understands Danish
- Age between 18-70
Exclusion
- Blindness
- Cannot partake in second screening
Key Trial Info
Start Date :
February 28 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 14 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05276778
Start Date
February 28 2022
End Date
November 14 2023
Last Update
May 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Malene Krogh
Aalborg, DK, Denmark, 9000